The Anticoagulant Rivaroxaban Lowers Portal Hypertension in Cirrhotic Rats Mainly by Deactivating Hepatic Stellate Cells

Hepatology - United States
doi 10.1002/hep.29084
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Ammonia Produces Pathological Changes in Human Hepatic Stellate Cells and Is a Target for Therapy of Portal Hypertension

Journal of Hepatology
Hepatology
2016English

Pregnancy Outcome in Non-Cirrhotic Portal Hypertension

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2017English

Non-Cirrhotic Portal Hypertension in the HIV-infected Individual

Journal of the Royal Society of Medicine
Medicine
2013English

Gastrointestinal Bleeding in Cirrhotic Patients With Portal Hypertension

ISRN Hepatology
2013English

Individualized Treatment of Gastric Varices in Cirrhotic Portal Hypertension

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Idiopathic Non-Cirrhotic Portal Hypertension and Its Causes

GASTROENTEROLOGY
2018English

Non-Cirrhotic Portal Hypertension in an Ankylosing Spondylitis Patient

Yeungnam University Journal of Medicine
2018English

Impact of Farnesoid X Receptor SNPs on Hepatic Decompensation and Mortality in Cirrhotic Patients With Portal Hypertension

Journal of Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Sinusoidal Portal Hypertension in Hepatic Amyloidosis.

Gut
Gastroenterology
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy